/1033_3661.jpg)
Medicon Valley is a bi-national cluster that spans the island of Sealand in Eastern Denmark and the Skåne region of Southern Sweden. It is one of Europe's strongest life science clusters with a large number of life science companies located within a very small geographical area. Medicon Valley is characterised by a healthy business environment with world-class research and development. A unique interplay exists between companies, hospitals, universities, and public research institutions - in a successful application of the triple helix approach. Based on this model, interaction and networking take place among the various public and private life science players.
The major pharmaceutical corporations found in Medicon Valley - Novo Nordisk, AstraZeneca, LEO Pharma, H. Lundbeck, Nycomed, Ferring Pharma ceuticals and ALK-Abelló - constitute the backbone in what has become Europe's most densely packed life science cluster. Based on a long research commitment, the cluster holds core competences in therapeutic areas like diabetes/ metabolism, neuroscience, cancer, infl ammation and allergy. Furthermore, Medicon Valley is in the forefront of personalised medicine. The majority of the region's more than a hundred biotech companies have emerged since the mid-1990s. Many new companies have managed to bring their research forward into the clinical stages of development.
Get more information at www.mva.org or by contacting the Ambassador Programme Team.
|
Charlotte Ahlgren Moritz |